Analysis of patients' access to reimbursed biotechnological medicines for multiple sclerosis in Bulgaria and Greece.
Yoana SeitaridouIvo TsekovMaria KamushevaMaria DimitrovaGuenka PetrovaPublished in: Expert review of pharmacoeconomics & outcomes research (2021)
The existing legislative measures at the national level of Bulgaria and Greece ensure adequate and timely access of patients with MS to treatment.